Apogem Capital LLC Sio Gene Therapies Inc. Transaction History

Apogem Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.25 - $0.73 $12,382 - $36,155	-49,528 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $5,894 - $15,753	-10,717 Reduced 17.79%	49,528 $33,000
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $26,835 - $49,095	20,803 Added 52.74%	60,245 $78,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $36,274 - $54,110	20,041 Added 103.3%	39,442 $86,000
Q2 2021 Aug 16, 2021	BUY	$2.07 - $2.89 $7,400 - $10,331	3,575 Added 22.59%	19,401 $53,000
Q1 2021 May 14, 2021	BUY	$2.34 - $3.44 $37,032 - $54,441	15,826 New	15,826 $41,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.